1. Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[ 18 F] F and [ 18 F]FDG: a Focus on Skeletal Lesions.
- Author
-
Sonni I, Minamimoto R, Baratto L, Gambhir SS, Loening AM, Vasanawala SS, and Iagaru A
- Subjects
- Adult, Aged, Aged, 80 and over, Bone Neoplasms secondary, Breast Neoplasms pathology, Female, Humans, Image Processing, Computer-Assisted, Male, Middle Aged, Multimodal Imaging methods, Prospective Studies, Prostatic Neoplasms pathology, Radionuclide Imaging, Radiopharmaceuticals, Sodium, Technetium Tc 99m Medronate, Whole Body Imaging, Bone Neoplasms diagnostic imaging, Breast Neoplasms diagnostic imaging, Fluorodeoxyglucose F18, Magnetic Resonance Imaging, Positron-Emission Tomography, Prostatic Neoplasms diagnostic imaging, Sodium Fluoride
- Abstract
Purpose: The purpose of this study is to prospectively evaluate the performance of sodium
18 F]fluoride (Na[18 F]F)/2-deoxy-2-[18 F]fluoro-D-glucose ([18 F]FDG) simultaneous time-of-flight enabled positron emission tomography (PET)/magnetic resonance imaging (MRI) for the detection of skeletal metastases in selected patients with advanced breast and prostate cancers., Procedure: The institutional review board approved this HIPAA-compliant protocol. Written informed consent was obtained from each patient. A total of 74 patients (23 women and 51 men with breast and prostate cancer, respectively) referred for standard-of-care whole-body bone scintigraphy (WBBS) were enrolled in this prospective study. All patients underwent a [99m Tc]methyldiphosphonate ([99m Tc]MDP) WBBS followed by Na[18 F]F/[18 F]FDG PET/MRI. Lesions detected by each imaging modality were tabulated and a lesion-based and patient-based analysis was conducted., Results: On a patient-based analysis, [99m Tc]MDP WBBS identified skeletal lesions in 37 patients and PET/MRI in 45 patients. On a lesion-based analysis, WBBS identified a total of 81 skeletal lesions, whereas PET/MRI identified 140 lesions. Additionally, PET/MRI showed extra-skeletal lesions in 19 patients, including lymph nodes (16), prostate (4) lung (3), and liver (2) lesions., Conclusions: The ability of Na[18 F]F/[18 F]FDG PET/MRI to identify more skeletal lesions than99m Tc-MDP WBBS and to additionally identify extra-skeletal disease may be beneficial for patient care and represent an alternative to the single modalities performed separately. Na[18 F]F/[18 F]FDG PET/MRI is a promising approach for evaluation of skeletal and extra-skeletal lesions in a selected population of breast and prostate cancer patients.- Published
- 2020
- Full Text
- View/download PDF